Backed by GV.
About the role
Reporting directly to the Vice President, US Analytics & Insights, the Executive Director, US Portfolio Analytics will lead the portfolio-wide analytics capabilities that enable data-driven commercial decision-making across Revolution Medicines’ US business.
What they're looking for
- Bachelor’s degree in quantitative, scientific, engineering, or business discipline(s)
- 12+ years of relevant experience in biotechnology, pharmaceutical, life sciences, or consulting environments, with substantial experience in commercial analytics and progressive leadership responsibility consistent with Executive Director-level expectations
- Deep knowledge of pharmaceutical commercial data, including claims and prescription data, HCP and account data, CRM and field activity, payer and formulary/access data, specialty pharmacy and patient-services data, and digital engagement data
- Experience defining KPI frameworks, executive dashboards, and performance-management reporting that translate complex data into clear business insights and actions
- Experience partnering with Information Systems teams and business stakeholders on commercial data architecture, data quality, governance, business rules, and analytics platforms
- Demonstrated success supporting product launch readiness, commercialization, and post-launch performance optimization
More about this role
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
Reporting directly to the Vice President, US Analytics & Insights, the Executive Director, US Portfolio Analytics will lead the portfolio-wide analytics capabilities that enable data-driven commercial decision-making across Revolution Medicines’ US business. This leader will be accountable for Field Analytics, Market Access Analytics, Data Strategy & Governance, Omnichannel Analytics, and...
Browse similar: Startup jobs · San Francisco Bay Area